Ronen Samuel - 18 Mar 2026 Form 3 Insider Report for Kornit Digital Ltd. (KRNT)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: KRNT
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 12:10:56 UTC
Source filing: View source filing
Reporting owner signature: /s/ Assaf Zipori, attorney-in-fact

Key filing fact

Ronen Samuel filed Form 3 for Kornit Digital Ltd. (KRNT) on 18 Mar 2026.

Key facts

This page summarizes Ronen Samuel's Form 3 filing for Kornit Digital Ltd. (KRNT).
0 reported transactions and 8 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 12:10.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001990890 Primary reporting owner

Samuel Ronen

Relationship: Chief Executive Officer, Director
Address: C/O KORNIT DIGITAL LTD., 12 HA'AMAL ST., ROSH-HA'AYIN, ISRAEL
Signature: /s/ Assaf Zipori, attorney-in-fact
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KRNT holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 101,494
Date: 18 Mar 2026
Ownership: Direct

KRNT holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 11,788
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1

KRNT holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 13,095
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F2

KRNT holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 21,724
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F3

KRNT holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 39,967
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F4

KRNT holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 164,582
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F5

KRNT holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 32,302
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KRNT holding Derivative

Options (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 37,500
Exercise price: $28.15
Footnotes: F7

KRNT holding Derivative

Options (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 10,350
Exercise price: $57.79
Footnotes: F8

KRNT holding Derivative

Options (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 5,005
Exercise price: $122.19
Footnotes: F9

KRNT holding Derivative

Options (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 23,775
Exercise price: $35.51
Footnotes: F10

KRNT holding Derivative

Options (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 23,158
Exercise price: $22.02
Footnotes: F11

KRNT holding Derivative

Options (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 48,525
Exercise price: $23.00
Footnotes: F12

KRNT holding Derivative

Options (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 65,036
Exercise price: $16.48
Footnotes: F13

KRNT holding Derivative

Options (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 68,009
Exercise price: $15.19
Footnotes: F14

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 14 footnotes

Footnote F1

The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person on August 11, 2022 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 11, 2026).

Footnote F2

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on December 29, 2022 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (December 29, 2026).

Footnote F3

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2023 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2027).

Footnote F4

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2028).

Footnote F5

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2025 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs will vest and settle for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs will vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2029).

Footnote F6

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2025 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs will vest and settle for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs will vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2029).

Footnote F7

All options to purchase ordinary shares reported in this row fully vested and became exercisable prior to the date of this report.

Footnote F8

All options to purchase ordinary shares reported in this row fully vested and became exercisable prior to the date of this report.

Footnote F9

All options to purchase ordinary shares reported in this row fully vested and became exercisable prior to the date of this report.

Footnote F10

The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 11, 2022 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 11, 2026).

Footnote F11

The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on December 29, 2022 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (December 29, 2026).

Footnote F12

The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 12, 2023 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 12, 2027).

Footnote F13

The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 12, 2024 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 12, 2028).

Footnote F14

The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 12, 2025 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options will vest upon the one-year anniversary of the grant date, and an additional 6.25% of the options will vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 12, 2029).

SEC remarks

Exhibit 24.1 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .